Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Arerugi = [Allergy]|July 20, 2018
[SENSITIVITY OF FRUIT-SPECIFIC IgE SCREENING IN MULTI-PANEL ANTIBODY TESTING]Yuma Fukutomi, Takafumi Minami, Masami Taniguchi
International Journal of Urology : Official Journal of the Japanese Urological Association|October 17, 2024
Iodine-125 low-dose rate prostate brachytherapyTakafumi Minami, Saizo Fujimoto, Kazutoshi Fujita
Molecular Cancer|September 18, 2014
Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A systemNanae Harashima, Takafumi Minami, Hirotsugu Uemura, et al.
Journal of Contemporary Brachytherapy|December 6, 2017
Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapyMasahiro Inada, Masaki Yokokawa, Takafumi Minami, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 7, 2017
Hand eczema as a risk factor for food allergy among occupational kitchen workersTakafumi Minami, Yuma Fukutomi, Kiyoshi Sekiya, et al.
Histology and Histopathology|August 5, 2025
Treatment strategies for locally advanced and metastatic urothelial carcinoma based on molecular profiles: A ReviewMamoru Hashimoto, Ken Fukiage, Takafumi Minami, et al.
BJU International|February 16, 2012
Sorafenib rechallenge in patients with metastatic renal cell carcinomaMasahiro Nozawa, Yutaka Yamamoto, Takafumi Minami, et al.
International Archives of Allergy and Immunology|August 30, 2017
Lower Airway Inflammation in Eosinophilic Chronic Rhinosinusitis as Determined by Exhaled Nitric OxideRumi Kambara, Takafumi Minami, Hitoshi Akazawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2018
[Four Cases of Resected cN2 Stage III A Non-Small-Cell Lung Cancer after Induction Chemotherapy]Hideoki Yokouchi, Masaki Miyazaki, Takeaki Miyamoto, et al.
World Journal of Urology|August 30, 2022
Current status and future perspectives of the managements of metastatic hormone-sensitive prostate cancerNaoki Matsumura, Kazutoshi Fujita, Mitsuhisa Nishimoto, et al.
Pageof 9